Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition

NCT04344717 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Short Bowel Syndrome
Anticoagulation

Interventions

DRUG: Apixaban single dose
DRUG: Apixaban steady-state

Sponsor

Universitaire Ziekenhuizen KU Leuven